Real World Data is critical for understanding the true impact of treatments on cardiovascular disorders, providing insights that go beyond the confines of clinical trials. As we engage with the latest findings at the ESCCongress2024, it’s clear that robust data is the foundation of effective research. Our fit-for-purpose regulatory grade real world imaging datasets (RWiD) and multimodal longitudinal datasets are designed to meet the complex needs of pharmaceutical companies, ensuring your research is built on solid ground.